Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18184958 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)
Conditions: Severe Sepsis;   Septic Shock
Interventions: Drug: 10% Hemohes® (10% Hydroxyethyl starch);   Drug: Sterofundin® (Ringer lactate solution);   Drug: Actrapid® (Insulin)
2 Completed Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1
Condition: Hypoglycaemia
Interventions: Drug: GLP-1;   Drug: Placebo (Saline);   Drug: TNF-alfa;   Other: OGTT;   Other: IVGTT

Indicates status has not been verified in more than two years